National HealthCare Co. (NHC) Director James Paul Abernathy Sells 800 Shares

National HealthCare Co. (NYSEAMERICAN:NHC) Director James Paul Abernathy sold 800 shares of the business’s stock in a transaction that occurred on Wednesday, November 15th. The stock was sold at an average price of $64.00, for a total value of $51,200.00. Following the completion of the transaction, the director now directly owns 23,478 shares in the company, valued at $1,502,592. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Shares of National HealthCare Co. (NHC) traded down $0.29 during trading on Friday, reaching $63.50. The company’s stock had a trading volume of 24,638 shares, compared to its average volume of 25,267. National HealthCare Co. has a 12 month low of $57.73 and a 12 month high of $78.99.

National HealthCare (NYSEAMERICAN:NHC) last issued its earnings results on Thursday, November 9th. The company reported $0.75 earnings per share for the quarter. National HealthCare had a return on equity of 6.26% and a net margin of 4.41%. The business had revenue of $241.99 million during the quarter.

The company also recently announced a quarterly dividend, which will be paid on Thursday, March 1st. Shareholders of record on Friday, December 29th will be issued a $0.48 dividend. This represents a $1.92 annualized dividend and a dividend yield of 3.02%. The ex-dividend date of this dividend is Thursday, December 28th. National HealthCare’s dividend payout ratio is 60.00%.

WARNING: “National HealthCare Co. (NHC) Director James Paul Abernathy Sells 800 Shares” was posted by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this story on another website, it was copied illegally and republished in violation of United States & international copyright and trademark law. The correct version of this story can be accessed at https://sportsperspectives.com/2017/11/18/national-healthcare-co-nhc-director-james-paul-abernathy-sells-800-shares.html.

Hedge funds have recently modified their holdings of the business. Acrospire Investment Management LLC lifted its holdings in shares of National HealthCare by 235.0% in the 2nd quarter. Acrospire Investment Management LLC now owns 1,568 shares of the company’s stock worth $110,000 after buying an additional 1,100 shares during the period. BNP Paribas Arbitrage SA lifted its holdings in shares of National HealthCare by 286.1% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 2,081 shares of the company’s stock worth $146,000 after buying an additional 1,542 shares during the period. SG Americas Securities LLC purchased a new stake in shares of National HealthCare in the 3rd quarter worth $155,000. Legal & General Group Plc lifted its holdings in shares of National HealthCare by 3.0% in the 2nd quarter. Legal & General Group Plc now owns 2,769 shares of the company’s stock worth $195,000 after buying an additional 81 shares during the period. Finally, Principal Financial Group Inc. purchased a new stake in shares of National HealthCare in the 2nd quarter worth $206,000.

Several equities analysts have commented on the company. BidaskClub raised National HealthCare from a “strong sell” rating to a “sell” rating in a research report on Tuesday, September 12th. ValuEngine downgraded National HealthCare from a “hold” rating to a “sell” rating in a research report on Monday, October 2nd.

National HealthCare Company Profile

National HealthCare Corporation (NHC) is engaged in the operation of skilled nursing facilities, assisted living facilities, independent living facilities and homecare programs. The Company is engaged in the post-acute healthcare industry segment. Its business activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer’s care, senior living services, and home healthcare services.

Insider Buying and Selling by Quarter for National HealthCare (NYSEAMERICAN:NHC)

Receive News & Ratings for National HealthCare Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National HealthCare Co. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply